The New York Entrepreneur

Vaxcyte’s stock dips after biotech completes $1.42 billion stock offering

Read Time:7 Second

Vaxcyte Inc.’s stock fell 3% early Friday, after the company completed a stock offering that is expected to generate $1.42 billion in proceeds.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Previous post Borrowers feel ‘hopeless’ as debt relief flip-flops at the whim of those with power over their student loans
Next post MIT and Yale’s New Class Profiles Post Affirmative Action Ban